(Q30393980)

21 June 2017

title

Nanotechnology and HIV: potential applications for treatment and prevention (English)

1 reference

21 June 2017

0 references

prevention of HIV/AIDS

0 references

author name string

Peter S. Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20860050

18 July 2024

Sarah W. Read

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20860050

18 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20860050

18 July 2024

publication date

1 November 2010

1 reference

full work available at URL

21 June 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fwnan.118

1 reference

https://api.crossref.org/works/10.1002/WNAN.118

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.118

18 July 2024

1 reference

https://api.crossref.org/works/10.1002/WNAN.118

https://onlinelibrary.wiley.com/doi/full-xml/10.1002/wnan.118

18 July 2024

1 reference

https://api.crossref.org/works/10.1002/WNAN.118

https://wires.onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.118

18 July 2024

1 reference

https://api.crossref.org/works/10.1002/WNAN.118

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

18 July 2024

published in

1 reference

21 June 2017

volume

2

1 reference

21 June 2017

issue

6

1 reference

21 June 2017

page(s)

693-702

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

HIV entry inhibitors and their potential in HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Novel approaches to inhibiting HIV-1 replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Class-sparing regimens for initial treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

The challenge of finding a cure for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Dendrimers as biopharmaceuticals: synthesis and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Lipid–Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Nanochemistry-based immunotherapy for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Challenges in the development of an HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Nanotechnology in vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Mechanism of action of licensed vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Microbicides for HIV prevention: reality or hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FWNAN.118

Universal voluntary testing and treatment for prevention of HIV transmission

21 January 2018

https://api.crossref.org/works/10.1002/WNAN.118

5

1 reference

Decreased lung carcinoma cell density on select polymer nanometer surface features for lung replacement therapies

18 July 2024

https://api.crossref.org/works/10.1002/WNAN.118

23

1 reference

pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute

18 July 2024

https://api.crossref.org/works/10.1002/WNAN.118

29

1 reference

Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine

18 July 2024

https://api.crossref.org/works/10.1002/WNAN.118

39

1 reference

Adjuvanticity of stealth liposomes on the immunogenicity of synthetic gp41 epitope of HIV-1

18 July 2024

https://api.crossref.org/works/10.1002/WNAN.118

44

1 reference

Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge

18 July 2024

https://api.crossref.org/works/10.1002/WNAN.118

57

1 reference

SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques

18 July 2024

https://api.crossref.org/works/10.1002/WNAN.118

72

1 reference

18 July 2024

Identifiers

DOI

10.1002/WNAN.118

1 reference

21 June 2017

1 reference